Pilavapadin is an investigational small molecule inhibitor of adaptor-associated kinase 1 (AAK1) currently under study for its potential to treat neuropathic pain, including diabetic peripheral neuropathic… Read more
Pilavapadin is an investigational small molecule inhibitor of adaptor-associated kinase 1 (AAK1) currently under study for its potential to treat neuropathic pain, including diabetic peripheral neuropathic pain. This category contains essential reference standards, including pilavapadin impurities, metabolites, and stable isotope-labelled compounds, which are vital for precise analytical testing within pharmaceutical research and development. These reference materials enable laboratories to perform rigorous impurity profiling and ensure the accuracy of method validation protocols. By utilizing stable isotope-labelled analogues, researchers can achieve enhanced sensitivity and specificity in complex bioanalytical studies and pharmacokinetic investigations. These compounds serve as critical benchmarks for quality control, supporting reliable identity testing, quantitative analysis, and stability studies required throughout the lifecycle of the drug substance.